These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25162714)

  • 41. Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis.
    Passiglia F; Bronte G; Bazan V; Galvano A; Vincenzi B; Russo A
    Crit Rev Oncol Hematol; 2016 Mar; 99():150-7. PubMed ID: 26775732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases.
    Spelt L; Sasor A; Ansari D; Andersson R
    Scand J Gastroenterol; 2016 Oct; 51(10):1233-8. PubMed ID: 27306604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity.
    Viganò L; Ferrero A; Lo Tesoriere R; Capussotti L
    Ann Surg Oncol; 2008 Sep; 15(9):2458-64. PubMed ID: 18463927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term and long-term outcomes after simultaneous resection of colorectal malignancies and synchronous liver metastases.
    de Santibañes E; Fernandez D; Vaccaro C; Quintana GO; Bonadeo F; Pekolj J; Bonofiglio C; Molmenti E
    World J Surg; 2010 Sep; 34(9):2133-40. PubMed ID: 20532766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantification of risk of a positive (R1) resection margin following hepatic resection for metastatic colorectal cancer: an aid to clinical decision-making.
    Welsh FK; Tekkis PP; O'Rourke T; John TG; Rees M
    Surg Oncol; 2008 Jul; 17(1):3-13. PubMed ID: 18222689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.
    Reddy SK; Zorzi D; Lum YW; Barbas AS; Pawlik TM; Ribero D; Abdalla EK; Choti MA; Kemp C; Vauthey JN; Morse MA; White RR; Clary BM
    Ann Surg Oncol; 2009 Jul; 16(7):1809-19. PubMed ID: 18979139
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timing of resection for synchronous liver metastases from colorectal cancer.
    Kaibori M; Iwamoto S; Ishizaki M; Matsui K; Saito T; Yoshioka K; Hamada Y; Kwon AH
    Dig Dis Sci; 2010 Nov; 55(11):3262-70. PubMed ID: 20112062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree model.
    Tseng CW; Teng HW; Lin CC; Lei HJ; Hung JJ; Liang WY; Hsia CY; Chou SC; Lin HH; Huang SC; Cheng HH; Lan YT; Wang HS; Yang SH; Chen WS; Lin JK; Jiang JK; Chang SC; Chau GY
    J Chin Med Assoc; 2023 Aug; 86(8):732-739. PubMed ID: 37294150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.
    Hasegawa Y; Nitta H; Sasaki A; Takahara T; Itabashi H; Katagiri H; Otsuka K; Nishizuka S; Wakabayashi G
    Surgery; 2015 Jun; 157(6):1065-72. PubMed ID: 25791030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
    Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
    Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Vauthey JN; Zimmitti G; Kopetz SE; Shindoh J; Chen SS; Andreou A; Curley SA; Aloia TA; Maru DM
    Ann Surg; 2013 Oct; 258(4):619-26; discussion 626-7. PubMed ID: 24018645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of preoperative prognostic factors for long-term survival after hepatic resection of liver metastasis of colorectal carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Matsumoto T; Ohta M; Kitano S
    J Gastrointest Surg; 2005 Mar; 9(3):374-80. PubMed ID: 15749600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative Analysis between Simultaneous Resection and Staged Resection for Synchronous Colorectal Liver Metastases - A Single Center Experience on 300 Consecutive Patients.
    Alexandrescu S; Diaconescu A; Ionel Z; Zlate C; Grigorie R; Hrehoreţ D; Braşoveanu V; Dima S; Botea F; Ionescu M; Tomescu D; Droc G; Fota R; Croitoru A; Gramaticu I; Buica F; Iacob R; Gheorghe C; Herlea V; Grasu M; Dumitru R; Boroş M; Popescu I
    Chirurgia (Bucur); 2017; 112(3):278-288. PubMed ID: 28675363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
    Teng HW; Huang YC; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Wang HW; Chang SC; Lan YT; Lin CC; Wang HS; Yang SH
    J Surg Oncol; 2012 Aug; 106(2):123-9. PubMed ID: 22331825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases.
    Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Sekido H; Togo S
    Surgery; 2004 Sep; 136(3):650-9. PubMed ID: 15349115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.